Scientists discovered QT12 gene system in rice that doubles crop yields under heat stress, offering breakthrough solution for food security as global temperatures rise and threaten agricultural production worldwide.
Researchers have successfully sequenced the first complete ancient genome from Egypt’s Old Kingdom period, revealing unexpected genetic connections between early dynastic Egypt and Mesopotamian populations. The study, published in Nature, fills a critical 3,000-year gap in our understanding of ancient Egyptian population genetics.
Scientists analyzed 2,762 Indian genomes revealing 50,000 years of evolutionary history and discovered over 160,000 new disease-causing genetic variants that could transform medical care for billions globally.
New research identified altered microRNA expression patterns in female OCD patients, with miR-132 increased and miR-125b-5p decreased compared to healthy controls. Higher plasma serotonin levels and positive correlation between dopamine and symptom severity suggest potential biomarkers for OCD diagnosis.
Despite affecting 77% of women by menopause, uterine fibroid research faces critical limitations due to inadequate animal models that fail to replicate human disease pathophysiology, genetic patterns, and tissue characteristics, forcing scientists to develop innovative three-dimensional cell culture alternatives for better treatment development.
Anilocus provides comprehensive mutagenicity testing services including bacterial mutation assays, mammalian cell gene mutation studies, and in vivo mutagenicity testing to assess genetic mutation potential and support regulatory submissions for drug development programs.
Artificial intelligence is revolutionizing medical imaging by analyzing X-rays, MRIs, and CT scans with promising results in some areas while facing significant challenges in others, helping doctors detect diseases more efficiently when properly implemented.
Clinical trials advance through four phases testing drug safety and effectiveness, with only 13.8% of treatments successfully reaching FDA approval after rigorous testing in thousands of patients over multiple years.
Global pharmaceutical pipeline shows 12,500 drugs in preclinical development while market grows to $71 billion, with contract research organizations like Anilocus accelerating breakthrough therapies from discovery to clinical trials through specialized services.
Bold ideas and breakthrough research. Expert analysis on the innovations and drug development for the most important people in the world: patients.
Use this form to send your questions to our research team about our preclinical contract research services.
We are here to help!
